Clinical Trial: A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naive Acute Myeloid Leukemia (AML): DLIT-AML

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07014462) titled 'A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naive Acute Myeloid Leukemia (AML): DLIT-AML' on May 06.

Brief Summary: This study is investigating whether adding dexamethasone, an anti-inflammatory medication, to a standard venetoclax-based low-intensity therapy (LIT) is safe and well-tolerated in patients with newly diagnosed Acute Myeloid Leukemia (AML) who are not eligible for intensive chemotherapy.

Study Goals Primary Goal: To assess the safety and tolerability of dexamethasone in combination with venetoclax-b...